Correlation Between Crispr Therapeutics and Tachlit Indices

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Crispr Therapeutics and Tachlit Indices at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crispr Therapeutics and Tachlit Indices into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Crispr Therapeutics AG and Tachlit Indices Mutual, you can compare the effects of market volatilities on Crispr Therapeutics and Tachlit Indices and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crispr Therapeutics with a short position of Tachlit Indices. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crispr Therapeutics and Tachlit Indices.

Diversification Opportunities for Crispr Therapeutics and Tachlit Indices

0.48
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Crispr and Tachlit is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Crispr Therapeutics AG and Tachlit Indices Mutual in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tachlit Indices Mutual and Crispr Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crispr Therapeutics AG are associated (or correlated) with Tachlit Indices. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tachlit Indices Mutual has no effect on the direction of Crispr Therapeutics i.e., Crispr Therapeutics and Tachlit Indices go up and down completely randomly.

Pair Corralation between Crispr Therapeutics and Tachlit Indices

Given the investment horizon of 90 days Crispr Therapeutics AG is expected to generate 1.59 times more return on investment than Tachlit Indices. However, Crispr Therapeutics is 1.59 times more volatile than Tachlit Indices Mutual. It trades about 0.03 of its potential returns per unit of risk. Tachlit Indices Mutual is currently generating about -0.02 per unit of risk. If you would invest  4,908  in Crispr Therapeutics AG on January 26, 2024 and sell it today you would earn a total of  657.00  from holding Crispr Therapeutics AG or generate 13.39% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy80.65%
ValuesDaily Returns

Crispr Therapeutics AG  vs.  Tachlit Indices Mutual

 Performance 
       Timeline  
Crispr Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Crispr Therapeutics AG has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Crispr Therapeutics is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.
Tachlit Indices Mutual 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tachlit Indices Mutual has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Etf's technical and fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the ETF investors.

Crispr Therapeutics and Tachlit Indices Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Crispr Therapeutics and Tachlit Indices

The main advantage of trading using opposite Crispr Therapeutics and Tachlit Indices positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crispr Therapeutics position performs unexpectedly, Tachlit Indices can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tachlit Indices will offset losses from the drop in Tachlit Indices' long position.
The idea behind Crispr Therapeutics AG and Tachlit Indices Mutual pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.

Other Complementary Tools

Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format